A Wind of Change in the EU’s Pharmaceutical Landscape
The challenge that the European Commission set itself up for in revising the EU’s Pharmaceutical Legislation (namely Directive 2001/83/EC1 an...
Colores Finland Shares Effort to Support People Living with Lynch Syndrome
Lynch Syndrome impacts several areas of life. Patients can benefit from collaboration with specialists across many fields, especially input from Ly...
EuropaColon Poland Received “Swallow of Hope Award”
Congratulations to our member organisation EuropaColon Poland Foundation for Patients, on receiving the “Swallow of Hope”, a national Polish aw...
TOGAS: Towards Gastric Cancer Screening Implementation in the European Union
On 30 – 31 March, DiCE participated in the kick-off meeting of the TOGAS project held in Riga, Latvia. TOGAS, which stands for TOwards GAstri...
Liver Cancer Index – The Mapping Survey Is Available Online
The survey was created to map the liver cancer treatment landscape across the EU and is now available online and disseminated among several relevan...
Scientists Propose A Novel Approach For The Treatment Of Liver Cancer
The Nature Cancer journal recently published promising results from cell and mouse studies by liver cancer specialists at the Massachusetts General...
EuropaColon Slovenia Celebrates Its 15th Anniversary
This March EuropaColon Slovenia rang in its 15th anniversary as a patient association! EC Slovenia was an original member of EuropaColon, the Europ...
Primary Findings From The GLOW Study Signals Positive Momentum In The Development Of Novel Therapeutic Options For Patients With HER2-Negative Locally Advanced Unresectable Or Metastatic Gastric & GEJ Cancers
At the end of 2022, leaders of the Phase 3 clinical trial GLOW shared their positive primary findings. GLOW (NCT03653507) is a global, multicenter,...
Trastuzumab Deruxtecan Meets Objective Response Rate Endpoint in Several Types of HER2-expressing Advanced Solid Tumours
Positive topline results of the ongoing DESTINY-PanTumour02 Phase II trial (NCT04482309) showed that treatment with trastuzumab deruxtecan met the...
The First International Management Guidelines for Early-Onset Colorectal Cancer
This March, the Clinical Gastroenterology and Hepatology journal published the first management guidelines for Early-Onset Colorectal Cancer (eo-CR...
